Union Budget 2026 countdown begins: Explore expectations for tax cuts, divestment, and economic growth. Stay updated on key announcements!

Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

The Central Board of Secondary Education schedules Class 10 and 12 exams from February 17, 2026, highlighting key questions and topics.

Explore how to prepare for NEET exam with the help of PrepMed. Find out tips, strategies, and approaches that will assist you ...

According to Towards FnB, the global fragrance ingredients market size is calculated at USD 19.27 billion in 2026 and is ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic target for tauopathies.

Many of us like to think that we’re fairly smart. But it can be a very humbling experience when you’re in the presence of ...

Like John Wick? Check out glimpse Netflix series also made by its creator Derek Kolstad.

CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generation Bio, which once ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...